Idex Corp. price target raised to $230 from $210 at Oppenheimer

Oppenheimer analyst Bryan Blair raised the firm’s price target on Idex Corp. (IEX) to $230 from $210 and keeps an Outperform rating on the shares. The firm notes the company posted a relatively clean Q4 2025 beat supported by Health and Science Technologies topline and margin outperformance. Oppenheimer believes HST’s secular growth runway, Fluid and Metering Technologies’ short-cycle industrial leverage, and incremental/accretive capital deployment all support forward earnings and cash flow upside.